SSGJ-612

Other Medications

2 Clinical Trials

Description

SSGJ-612 is an investigational medication currently being studied in clinical trials for advanced solid tumors, including colorectal cancer. It is being evaluated in Phase 1 and Phase 2 trials to determine its safety, find the right dose, and see if it has anti-cancer activity. The trials are looking at patients whose tumors have specific characteristics related to HER2 (HER2 mutation or HER2 expression). The goal of the Phase 1 trials is to find the highest dose that can be given safely (Maximum Tolerated Dose or MTD) and to understand the side effects. Phase 2 trials will then expand the study to more patients at certain dose levels to further evaluate safety and effectiveness.

Mechanism of Action

The specific way SSGJ-612 works (its mechanism of action) is still being investigated in clinical trials. It is designed to target cancer cells, and its activity is being studied in patients with tumors that have certain HER2 characteristics.

Side Effects

SSGJ-612 is still in early-phase clinical trials (Phase 1 and Phase 2). Therefore The full range of potential side effects is still being evaluated. The Phase 1 trials focus on determining the safety profile and identifying dose-limiting toxicities (side effects that are severe enough to stop treatment or lower the dose). Information about specific side effects observed in the trials is not yet widely available But will become clearer as the trials progress.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT07646626 Phase 2
Recruiting
SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors
China
NCT07032298 Phase 1
Recruiting
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
China

Quick Info

CategoryOther Medications
Clinical Trials2
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
785 trials
Leucovorin
Other Medications
646 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.